Trial intelligence / Profile preview

Prospective, Randomized Study for Drug Interaction of Tegoprazan in Kidney Transplant Recipients Using Smart Clinical Trial Technology

KCT0010481Phase 4Completed

Sponsor
Korea Institute for Advancement of Technology
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tegoprazan in Kidney allograft status (RTx), sponsored by Korea Institute for Advancement of Technology. Started Aug 2022; status: completed.

02

Drugs

tegoprazan
03

Conditions

Kidney allograft status (RTx)

Beyond the preview

Go deeper on KCT0010481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0010481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call